Related Experiment Video
Updated: Jun 4, 2026
09:45
Measuring Cardiac Autonomic Nervous System (ANS) Activity in Children
Published on: April 29, 2013
Impaired autonomic function in normotensive obese children
Peter L Latchman1, Madhu Mathur, Matthew N Bartels
1Department of Rehabilitation Medicine, Teachers College, Columbia University and Columbia University Medical Center, 630 West 168th Street, Box 38, New York City, NY 10032, USA. pll2101@columbia.edu
Summary
Obese children show reduced baroreflex sensitivity and altered autonomic control, indicating potential dysfunction even with normal blood pressure. This highlights the need for early awareness of autonomic issues in pediatric obesity.
Area of Science:
- Pediatric Cardiology
- Autonomic Nervous System Function
- Obesity Research
Background:
- Childhood obesity is a growing concern with potential long-term health implications.
- Autonomic nervous system (ANS) dysfunction may precede cardiovascular complications in obese individuals.
- Understanding ANS control in normotensive obese children is crucial for early intervention.
Purpose of the Study:
- To investigate baroreflex sensitivity (BRS) and autonomic control in normotensive obese children.
- To compare ANS function between obese and normal-weight children.
- To identify potential early signs of autonomic dysfunction in pediatric obesity.
Main Methods:
- A cross-sectional study involving normotensive obese children and normal-weight controls.
- Noninvasive evaluation of BRS and autonomic control using transfer function and power spectral density analysis (PSDA).
- Analysis of electrocardiogram and beat-to-beat blood pressure data during seated, resting conditions.
Main Results:
- Obese children had significantly reduced baroreflex sensitivity and high-frequency heart rate variability (HFRR).
- Increased low-frequency systolic blood pressure (LFSBP) and LF/HF ratio were observed in obese children.
- Both groups were similar in age and normotensive blood pressure levels.
Conclusions:
- Normotensive obese children exhibit impaired baroreflex sensitivity and reduced parasympathetic control.
- Increased sympathetic activity was noted in obese children compared to controls.
- Autonomic dysfunction is present in young, normotensive obese children, warranting further investigation and awareness.
Related Concept Videos
01:18Disorders of the Autonomic Nervous System
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's phenomenon, is a...
Raynaud's disease, also known as Raynaud's phenomenon, is a...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...